Trump's Crypto Blueprint Unveils This Infrastructure Powerhouse
One blockchain token sits at the heart of Washington's pro-crypto agenda. Institutions are loading up while it still trades at a discount. Here's how to get in for $3.
| Open | 49.91 | Prev Close | 52.35 |
| High | 49.92 | Low | 48.58 |
| Volume | 4,670,843 | Volume (Avg) | 2,918 |
| 52 Week High | 57.57 | 52 Week Low | 43.86 |
| Market Cap | 120.3B | PE Ratio | 20.62 |
General
| Name | Sanofi ADR |
| Ticker | SNY |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 82,878 |
About Sanofi ADR
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. The company provides immunology and inflammation, rare diseases, neurology, oncology, and other medicines and vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines protecting against diphtheria, tetanus, pertussis, polio, Hib, and hepatitis B; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, yellow fever, and rabies vaccines. In addition, the company has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301, a treatment for alpha-synucleinopathies; Innate Pharma SA for a natural killer cell engager program targeting B7-H3; and Blackstone Life Sciences to develop pivotal studies and clinical development program. Further, it has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Kymera Therapeutics, Inc. to develop and commercialize protein degrader therapies targeting IRAK4 in patients with immune-inflammatory diseases; Nurix Therapeutics, Inc. to develop novel targeted protein degradation therapies; Denali Therapeutics Inc. to treat a range of systemic inflammatory diseases, such as ulcerative colitis; and Adagene Inc. for the discovery and development of antibody-based therapies. Additionally, it has a collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.
Highlights
| Analyst Target | 66.40 |
| Market Cap | 120,288,000,000 |
| PE Ratio | 20.62 |
| PEG Ratio | 0.85 |
| EBITDA | 12,147,999,744 |
Valuation
| Trailing PE | 17.63 |
| Forward PE | 11.26 |
| Price/Sales (Trailing 12 Mt.) | 2.78 |
| Price/Book (Most Recent Quarter) | 1.52 |
Technicals
| Beta | 0.51 |
| 52 Week High | 57.57 |
| 52 Week Low | 43.86 |
| 50 Day Average | -6.31% |
| 200 Day Average | -6.97% |
Dividend
Sanofi ADR pays out a dividend of $2.34 per share, with a dividend yield of 4.73%.
SNY's next dividend payment will be made to shareholders on June 12, 2025.
They pay out 66.96% of their earnings out as a dividend.
Recent Dividends
| Jun 12, 2025 | $2.21 |
| Jun 6, 2024 | $2.04 |
Business News Digest
AP Business Digest
Elon Musk's Ex-Wife Spills the Truth About Becoming a Billionaire
Justine Musk, the first wife of billionaire Elon Musk, offered her unique perspective on the journey to becoming a billionaire.
Wall Street Says BUY GOLD, But... - Ad
While markets wobble, gold keeps smashing records-and banks say it's just beginning. Goldman urges "buy gold" to hedge trade wars; JPMorgan plans $6,000 an ounce and just took delivery of $4 billion in bullion. Yet past bull runs saw 13x-1,000x bigger gains without buying more gold.
Social Security Full Retirement Age Shift Could See Your Check Chopped By 30% — What Everyone Born In 1960 Or Later Must Know
Retirement age for full Social Security benefits will be 67 in 2025, but claiming early will result in lower checks. Here's what everyone needs to know.
Trump's big tax bill has passed the House. Here's what's inside it
WASHINGTON (AP) — House Republicans early Thursday took a major step forward on President Donald Trump’s agenda, approving a legislative package that combines tax breaks, spending cuts, border security funding and other priorities.
Nvidia Is About to Shock the World: July 23rd - Ad
Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%, is warning everyone to... Mark this date on your calendar: July 23rd! That's when Nvidia could help send shares of this Elon Musk supplier skyrocketing higher.
Toll Brothers, D-Wave Quantum, Palo Alto Networks, Warby Parker, Tesla: Why These 5 Stocks Are On Investors' Radars Today
U.S. stock markets experienced a downturn today, with the Nasdaq dropping over 75 points or nearly 0.4% to 19,142.71.
FDA approves Novavax COVID-19 shot but with unusual restrictions
WASHINGTON (AP) — The Food and Drug Administration has issued a but with unusual restrictions.
Elon Musk Drops Stunning Bombshell? - Ad
Behind closed doors, Musk revealed a game-changing breakthrough technology that could shake the tech world & crush major companies. Why is no one talking about it? Luckily, we had a man on the inside - watch now to see the details & how to profit!
Elon Musk's PAC Promised $100 Per Signature—Now It's Facing a Lawsuit
Elon Musk is facing a lawsuit filed by three swing state voters. The plaintiffs allege that Musk failed to fulfill his promise of payment for signing a petition from his political action committee, America PAC.
SCHD: The Dividend ETF Turning Quiet Compounding Into Long-Term Wealth
Dividend growth investing may not be flashy, but it quietly creates lasting wealth for retirement. SCHD is a standout among dividend ETFs.
This Coin Could Surge Like Bitcoin Did Back in 2013... - Ad
A new coin is emerging in the crypto world. And investing in it now could end up like Bitcoin or Ethereum during their first bull runs.
Can Apple's AI Tabletop Robot Snap Its Stock Slump?
Apple is developing an AI-powered tabletop robot as a major new product category focused on blending robotics and AI for the home. But can it save the struggling tech stock?
Palantir Stock Is Trading Higher Thursday: What's Going On?
Palantir Technologies Inc (NASDAQ:PLTR) shares are trading higher Thursday. The stock appears to be benefiting from an Army contact modification announced after the market close on Wednesday.
A Historic Gold Announcement Is About to Rock Wall Street - Ad
The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent - and four tiny miners could be your ticket to 100X gains.
Chuck Schumer Blasts Trump For Backing AI Chip Sales To Saudi Arabia, UAE: 'This Deal Could Very Well Be Dangerous'
Senator Chuck Schumer warned that Trump-backed AI chip deals with Saudi Arabia and the UAE could risk U.S. tech secrets falling into China's hands, undermining national security and export restrictions.
Satellite Imagery Uncovers Serious Damage To North Korea's Newest Warship
Satellite images reveal a toppled North Korean warship, exposing serious damage and sparking a rare public probe ordered by Kim Jong Un.
Trump's Crypto Blueprint Unveils This Infrastructure Powerhouse - Ad
One blockchain token sits at the heart of Washington's pro-crypto agenda. Institutions are loading up while it still trades at a discount. Here's how to get in for $3.
'Big Short' Investor Michael Burry Turns Bearish On China: What's On His Short List Now
Michael Burry's hedge fund turns bearish on Chinese tech stocks.
Bitcoin Breaks $107,000, Ethereum Dips, Dogecoin Rallies As 'Greed' Sentiment Takes Over: Analyst Predicts BTC 'Primed' For A New All-Time High
Leading cryptocurrencies rallied sharply on Sunday as investors awaited new all-time highs for Bitcoin.
Thinking Of Buying Gold? Consider This ... - Ad
Gold is at record highs-up 22:1 vs stocks, 2:1 vs Bitcoin, soaring past $3,000/oz. But savvy investors historically have been able to multiply gold gains without buying bullion. Historically there have been gains 1,627X more than gold. Discover more about this gold amplifier in our urgent, free video today.
Trump's tariffs will test unity among allies at G7 finance ministers' summit
BANFF, Canada (AP) — Leading financial officials from the world's richest countries are gathering in a Canadian mountain resort this week for what may prove a contentious meeting in the wake of President Donald Trump's .
Mercedes-Benz will establish its North American HQ in Georgia, moving hundreds of jobs
ATLANTA (AP) — Mercedes-Benz announced Thursday that it plans establish its North American headquarters in metro Atlanta, where the automaker will expand its existing U.S. corporate hub by adding hundreds of jobs relocated from other cities.
You Can Take a Stake in Elon's xAI Before June 1st... - Ad
Elon Musk's private AI firm xAI may have just leapfrogged ChatGPT and Google's Gemini--building what experts call the future of AI. For the first time, you can take a stake starting at $500.
Bitcoin Extends Rally From May Lows — Can It Break $120,000 Next?
Bitcoin (CRYPTO: BTC) is continuing its run, with analysts now eyeing the $115,000–$120,000 range as the next logical targets.
iPhones, AI, And Alibaba: Why Apple's China Bet Alarms Donald Trump
Apple's AI partnership with Alibaba for Chinese iPhones faces U.S. backlash over national security and data-sharing concerns.
The Most Important "AI Stock" You've Never Heard Of - Ad
The AI revolution is moving faster than anyone expected. But what no one is talking about is the one company AI simply can't exist without. It may be the single most important AI investment, yet most people don't even know its name. For now. The moment Wall Street catches on, this $20 stock could explode.
UnitedHealth CEO, Other Insiders Buy Millions In Stock As It Sinks Over 23% In A Week: Move Gets 'Mixed' Reaction
As shares of UnitedHealth Group Inc. (NYSE: UNH) witness a steep decline, company insiders are stepping up to the plate with a series of insider buys, which analysts and experts say is "a strong signal."
Mark Cuban Once Suggested Gay NBA Players Could Profit: 'If You're a Player Who Happens To Be Gay and Want To Be Incredibly Rich, Then You Should Come Out'
Mark Cuban, the former owner of the Dallas Mavericks, once said that NBA players coming out as gay could see a significant increase in their income.
Brace Yourself for Jeff Bezos' "Amazon Helios" - Ad
Amazon delivers 20 million packages a day... powers some of the most popular websites... delivers medication to half of the U.S. population... and even produces award-winning films and TV shows. But a Wall Street legend -- twice featured on 60 Minutes -- predicts that "Amazon Helios" will be bigger than all of those... COMBINED.
Steak 'N Shake Thanks Bitcoin For Higher Sales, Lower Fees — And It's Celebrating With 'Blockchain Menu'
Restaurant company Steak ‘n Shake is a sponsor of the Bitcoin 2025 Conference and used the event to share an update on its recent push into Bitcoin (CRYPTO: BTC) as a payment option, as it also embraced the crypto community via
Trump Gives South African President The Zelenskyy Treatment, Hits Cyril Ramaphosa With Controversial Genocide Claims
=https://www.benzinga.com/25/04/20330998/senate-financial-disclosures-reveal-lucrative-investments-ahead-of-coronavirus-pandemic>Here's How They're Doing NowGet Ready For Why Is Donald Trump Obsessed With HydroxychloroquineA Complete Guide To Donald Trump XTrump showed video of alleged persecution of white farmers in South Africa. Ramaphosa questioned its credibility. Meeting also covered other issues.
This "Boring" Beer Stock Is Crushing It in 2025 (Time to Buy?) - Ad
Anheuser-Busch InBev (BUD) is one of the best-performing large-cap stocks in 2025. Time to buy? Only if you like leaving money on the table. Because there's a much smarter way you could make even more money on BUD starting today.
Portugal's election brings another minority government and a far-right rise
LISBON, Portugal (AP) — Portugal’s president was due to convene the country’s political parties for consultations on Monday, after a general election delivered another minority government as well as an unprecedented showing by that added momentum to .
How much did Mideast countries promise to invest in the US? Trump keeps jacking up the number
WASHINGTON (AP) — President Donald Trump loves big numbers — and he's always happy to talk them up.
A Better Hedge Than Gold? - Ad
While the whole world is piling into gold as a hedge... White House documents reveal Trump is betting big on a completely under-the-radar resource. This little-known resource is minting 1,600 millionaires every single day... And investors have a rare opportunity to take advantage before everyone else catches on.
Trump's meeting with Syria's former-insurgent-turned-leader to give the country 'chance at peace'
RIYADH, Saudi Arabia (AP) — President Donald Ahmad al-Sharaa, the onetime insurgent who last year led the overthrow of the Mideast nation's longtime autocrat Bashar Assad on Wednesday, a day after announcing his plan to ease sanctions on the country and normalize relations with its new government.
Taiwan's president downplays tariff tensions with the US as 'frictions between friends'
TAIPEI, Taiwan (AP) — The Taiwanese president said Tuesday that are just “frictions between friends” in a show of optimism as tariff negotiations are underway with Washington.
Revealed: Palm Beach Millionaire's Warning About "The Great Replacement" - Ad
A Wall Street veteran with a four-decade track record has issued a disturbing warning from his estate near Mar-a-Lago. He warns of an economic restructuring that will eliminate traditional career paths while creating unprecedented wealth opportunities.
Sanofi Boosts Alzheimer's Pipeline With Vigil Neuroscience Acquisition
Sanofi (SNY) to acquire Vigil Neuroscience (VIGL) for $470 million in cash, plus potential $2 per share payout. Acquisition excludes monoclonal antibody program and is expected to be finalized in Q3 2025. VG-3927 showed promise in Phase 1 for Alzheimer's treatment.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.